Distribution of espI among clinical enterohaemorrhagic and enteropathogenic Escherichia coli isolates

Rosanna Mundy, Claire Jenkins, Jun Yu, Henry Smith, Gad Frankel*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

44 Citations (Scopus)

Abstract

Enterohaemorrhagic (EHEC) and enteropathogenic (EPEC) Escherichia coli are important diarrhoeagenic pathogens; infection is dependent on translocation of a number of type III effector proteins. Until recently all the known effectors were encoded on the LEE pathogenicity island, which also encodes the adhesin intimin and the type III secretion apparatus. Recently, a novel non-LEE effector protein, EspI/NleA, which is required for full virulence in vivo and is encoded on a prophage, was identified. The aim of this study was to determine the distribution of espI among clinical EHEC and EPEC isolates, espI was detected in 86% and 53% of LEE+ EHEC and EPEC strains, respectively. Moreover, the espI gene was more commonly found in patients suffering from a more severe disease.

Original languageEnglish
Pages (from-to)1145-1149
Number of pages5
JournalJournal of Medical Microbiology
Volume53
Issue number11
DOIs
Publication statusPublished - Nov 2004

Fingerprint

Dive into the research topics of 'Distribution of espI among clinical enterohaemorrhagic and enteropathogenic Escherichia coli isolates'. Together they form a unique fingerprint.

Cite this